Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
112.15    0.45 (0.40%)
Bid:
112.15
Ask:
112.20
Spread: 0.05 (0.045%)
Market Cap: £65.20b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Completion of Placing and Compensatory Open Offer

8 Jun 2009 14:08

RNS Number : 5370T
Lloyds Banking Group PLC
08 June 2009
 

60/09 8 June 2009

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, HONG KONG, JAPAN, MALAYSIA, THAILAND OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

LLOYDS BANKING GROUP ANNOUNCES THE SUCCESSFUL COMPLETION OF THE PLACING AND COMPENSATORY OPEN OFFER AND PLACEMENT OF ALL NON ACCEPTED SHARES 

Unless otherwise defined in this announcement, capitalised definitions shall have the same meaning as in the prospectus ("the Prospectus") published on 20 May 2009 by Lloyds Banking Group plc (the "Company" or "Lloyds Banking Group") in connection with the Placing and Compensatory Open Offer.

Lloyds Banking Group plc today announces that Citigroup Global Markets U.K. Equity Limited, J.P. Morgan Cazenove Limited and UBS Limited (the "Joint Bookrunners") have today procured  placees for all of the 1,365,380,615 Open Offer Shares (representing approximately 13 per cent of the total number of Open Offer Shares) for which valid acceptances were not received under the Compensatory Open Offer (the "Rump"), at a price of 60 pence per Open Offer Share, a premium of 21.57 pence to the Issue Price of 38.43 pence per share. 

As set out in the Prospectus, the net proceeds from the placing of such Open Offer Shares (other than the fractional Open Offer Entitlements) in excess of the Issue Price (plus associated expenses) will be remitted on a pro rata basis to those Registered Shareholders who did not (or were deemed not to) take up, or were otherwise treated as not having taken up, their Open Offer Entitlements, save that amounts of less than £3.00 per holding will not be so paid but will be aggregated and donated to charity (the British Heart Foundation). The fractional Open Offer Entitlements were aggregated and placed for the benefit of the Company.

Eric Daniels, Group Chief Executive, Lloyds Banking Group, said: "We would like to thank our investors for their support for our successful Placing and Compensatory Open Offer.  We believe our shareholders will welcome the removal of the dividend blocker and the £480 million annual saving now we are redeeming the HMT preference shares.  The focus of our management team continues to be on ensuring a successful integration and delivering significant benefits for our shareholders in the medium to longer term."

Each of the Lloyds Banking Group Directors has taken up his or her Open Offer Entitlement in full.

Due to the take up under the Compensatory Open Offer by Lloyds Banking Group Qualifying Shareholders and following the placing of the Rump by the Joint Bookrunners, HM Treasury's holding in Lloyds Banking Group as a result of the Placing and Compensatory Open Offer remains unchanged at approximately 43.4 per cent of the enlarged issued ordinary share capital of the Company.  For further information:

Investor Relations

Michael Oliver +44 (0) 20 7356 2167

Director of Investor Relations

Email: michael.oliver@ltsb-finance.co.uk

Douglas Radcliffe +44 (0) 20 7356 1571

Senior Manager, Investor Relations

Email: douglas.radcliffe@ltsb-finance.co.uk

Media Relations

Shane O'Riordain +44 (0) 20 7356 1849

Group Communications Director

Email: shane.o'riordain@lloydsbanking.com

This announcement does not constitute a prospectus or prospectus equivalent document.  This announcement does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security.

This announcement does not constitute an offer to sell, or a solicitation of an offer to subscribe for, the securities being issued in any jurisdiction in which such offer or solicitation is unlawful. 

The Prospectus is available on the website of Lloyds Banking Group (www.lloydsbankinggroup.com) and in hard copy from Lloyds Banking Group's registered office.  Copies of the Prospectus are also available for viewing at the Document Viewing Facility of the FSA (25 The North Colonnade, London E14 5HS) and is available for inspection at Lloyds Banking Group's registered office (Henry Duncan House, 120 George Street, Edinburgh EH2 4LH) as well as at the offices of Linklaters LLP (One Silk Street, London EC2Y 8HQ) during normal business hours on any weekday (Saturdays, Sundays and public holidays excepted) until Admission.

This announcement is not for distribution, directly or indirectly, in or into the United States, Canada, Hong Kong, Japan, Malaysia, Thailand or any other state or jurisdiction in which it would be unlawful to do so. This announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The securities mentioned herein (the "Securities") have not been, and will not be, registered under the United States Securities Act of 1933 (the "Securities Act"). The Securities may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. There will be no public offer of the Securities in the United States. 

The Lloyds Banking Group Directors accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the Lloyds Banking Group Directors (who have taken all reasonable care to ensure that such is the case) the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

Citi and J.P. Morgan Cazenove Limited are each authorised and regulated by the Financial Services Authority in the United Kingdom and are acting for Lloyds Banking Group in connection with the Placing and Compensatory Open Offer and no-one else and will not be responsible to anyone other than Lloyds Banking Group for providing the protections afforded to their respective clients nor for providing advice in relation to the Placing and Compensatory Open Offer and/or any other matter referred to in this announcement. 

UBS Limited ("UBS") is acting for Lloyds Banking Group in connection with the Placing and Compensatory Open Offer and no-one else and will not be responsible to anyone other than Lloyds Banking Group for providing the protections afforded to its clients nor for providing advice in relation to the Placing and Compensatory Open Offer and/or any other matter referred to in this announcement. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEADKPEEANEFE
Date   Source Headline
10th Jul 20266:07 pmRNSTransaction in Own Shares
9th Jul 20266:03 pmRNSTransaction in Own Shares
8th Jul 20266:06 pmRNSTransaction in Own Shares
7th Jul 20266:02 pmRNSTransaction in Own Shares
6th Jul 20266:08 pmRNSTransaction in Own Shares
3rd Jul 20266:03 pmRNSTransaction in Own Shares
2nd Jul 20266:00 pmRNSTransaction in Own Shares
1st Jul 20266:10 pmRNSTransaction in Own Shares
1st Jul 20262:00 pmRNSAdmission to Trading
30th Jun 20265:52 pmRNSTransaction in Own Shares
30th Jun 20264:00 pmRNSTotal Voting Rights
29th Jun 20266:05 pmRNSTransaction in Own Shares
26th Jun 20266:05 pmRNSTransaction in Own Shares
26th Jun 20262:00 pmRNSDirector/PDMR Shareholding
25th Jun 20266:21 pmRNSTransaction in Own Shares
25th Jun 202610:38 amRNSNotification of Redemption
24th Jun 20266:01 pmRNSTransaction in Own Shares
23rd Jun 20266:16 pmRNSTransaction in Own Shares
22nd Jun 20266:14 pmRNSTransaction in Own Shares
19th Jun 20266:07 pmRNSTransaction in Own Shares
19th Jun 20263:59 pmRNSDirector/PDMR Shareholding
18th Jun 20266:10 pmRNSTransaction in Own Shares
17th Jun 20266:15 pmRNSTransaction in Own Shares
17th Jun 20262:00 pmRNSDirector/PDMR Shareholding
16th Jun 20266:07 pmRNSTransaction in Own Shares
16th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 20266:15 pmRNSTransaction in Own Shares
12th Jun 20262:00 pmRNSDirector/PDMR Shareholding
11th Jun 20266:16 pmRNSTransaction in Own Shares
10th Jun 20266:01 pmRNSTransaction in Own Shares
10th Jun 20262:54 pmRNSPublication of a Supplementary Prospectus
10th Jun 202611:09 amRNSBoard Change
9th Jun 20265:51 pmRNSTransaction in Own Shares
8th Jun 20266:09 pmRNSTransaction in Own Shares
8th Jun 202612:28 pmRNSAdmission to Trading
5th Jun 20266:21 pmRNSTransaction in Own Shares
4th Jun 20266:04 pmRNSTransaction in Own Shares
4th Jun 20263:34 pmRNSPublication of Final Terms
3rd Jun 20266:08 pmRNSTransaction in Own Shares
2nd Jun 20265:59 pmRNSTransaction in Own Shares
2nd Jun 202611:52 amRNSConsent Solicitation Results Announcement
1st Jun 20266:17 pmRNSTransaction in Own Shares
29th May 20266:11 pmRNSTransaction in Own Shares
29th May 20263:35 pmRNSTotal Voting Rights
29th May 20262:00 pmRNSDirector/PDMR Shareholding
28th May 20266:21 pmRNSTransaction in Own Shares
27th May 20266:03 pmRNSTransaction in Own Shares
26th May 20266:16 pmRNSTransaction in Own Shares
26th May 20262:00 pmRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSBlock Admission Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.